slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 85,141-85,170
Pages 3,683
Rows per page 30
Component
85,141-85,170 of 110,471
21
The slide uses a vertical timeline/process flow to show the progression of clinical development alongside key de-risking milestones.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
CIAS likely refers to Cognitive Impairment Associated with Schizophrenia.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
The slide uses a split-layout: left side provides market context and statistics, right side outlines the 'unaddressed need' framework.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · Market Sizing1 hit
02
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
11
The slide uses chemical structure diagrams to illustrate the relationship between the racemate and its enantiomers.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
24
The slide introduces the drug candidate VLS-01, providing its chemical identity and current clinical trial status.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
30
Slide 30. Includes statistical significance markers (*, **, ***).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
34
The slide uses a vertical process flow to show the progression from pre-clinical to clinical phases, mapped against key de-risking milestones.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
35
The slide uses a grouped bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) for four dosage groups.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
38
The slide uses a chemical structure diagram to establish the scientific basis for the product.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
The chart shows a significant p-value of 0.018 for NfL reduction. The study design is noted as randomized, double-blind, placebo-controlled, and parallel-group.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
07
The slide uses a list format to show progress/process steps.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The framework is a clinical trial decision matrix based on ADAS-Cog11 and ADCS-ADL23 scores.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
04
The slide features a high-quality illustration of neurons, emphasizing the CNS focus of the company.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
09
Includes a scientific diagram of the GABAa receptor complex.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution1 hit
28
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Team1 hit
30
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
06
The slide uses a bulleted list structure to present financial highlights compared to 3Q21 and 2Q22.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
07
Includes Basel 3 capital ratios and supplementary leverage ratios.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
11
Includes both GAAP and FTE (Fully Taxable-Equivalent) adjustments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
13
Includes a dual-axis chart for charge-offs and a waterfall-style bar chart for provisions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
16
Includes a footnote regarding non-GAAP financial measures.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
18
Includes footnotes detailing non-GAAP measures and business realignments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
21
Includes footnotes regarding data sources and methodology.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
24
Includes detailed footnotes regarding data sources and accounting adjustments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
25
The slide uses a structured layout to present key performance indicators across three thematic pillars.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
26
Includes detailed footnotes regarding data sources and exclusions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
28
Includes footnotes regarding non-GAAP measures and specific definitions for FICC and VaR.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
33
Bank of America | Results Presentation Deck | 36 slidesBank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations 1 hit
35
Bank of America | Results Presentation Deck | 36 slidesBank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations 1 hit